ARDS (MODERATE OR SEVERE)
Clinical trials for ARDS (MODERATE OR SEVERE) explained in plain language.
Never miss a new study
Get alerted when new ARDS (MODERATE OR SEVERE) trials appear
Sign up with your email to follow new studies for ARDS (MODERATE OR SEVERE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New inhaled drug tested for severe lung failure
Disease control Not yet recruitingThis early-stage trial will test the safety of a single inhaled dose of a lab-made protein (rhKGF-2) in 24 adults with moderate-to-severe ARDS who are on a breathing machine. Participants will receive either the study drug or standard care alone, and be monitored for 28 days for …
Matched conditions: ARDS (MODERATE OR SEVERE)
Phase: EARLY_PHASE1 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
New ventilation method aims to shield heart in severe pneumonia patients
Disease control Not yet recruitingThis study tests whether a special breathing machine strategy, guided by lung pressure measurements, can better protect the right side of the heart in patients with severe pneumonia and lung injury (ARDS). About 180 adults on breathing machines will be enrolled. The goal is to se…
Matched conditions: ARDS (MODERATE OR SEVERE)
Phase: NA • Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
Can a gas save lungs? new trial aims to cut ARDS deaths
Disease control Not yet recruitingThis study tests whether adding inhaled nitric oxide to standard care helps adults with moderate-to-severe acute respiratory distress syndrome (ARDS) survive longer. About 536 participants will receive either the gas or a placebo through a ventilator. Researchers will track death…
Matched conditions: ARDS (MODERATE OR SEVERE)
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated May 07, 2026 18:42 UTC